Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
PRNB | Principia Biopharma Inc. | George Simeon | Director | Sep 28, 2020 | Option Exercise | $100.00 | 2,982,855 | 298,285,500 | 0 | Sep 28, 2020, 05:27 PM | |
PRNB | Principia Biopharma Inc. | Becker Daniel J. | Director | Sep 28, 2020 | Option Exercise | $100.00 | 667,600 | 66,760,000 | 0 | Sep 28, 2020, 05:24 PM | |
PRNB | Principia Biopharma Inc. | Wolff Stefani | Chief Development Officer | Sep 28, 2020 | Option Exercise | $100.00 | 13,592 | 1,359,200 | 0 | Sep 28, 2020, 05:19 PM | |
PRNB | Principia Biopharma Inc. | Thomas Dolca | Chief Medical Officer | Sep 28, 2020 | Option Exercise | $100.00 | 2,207 | 220,700 | 0 | Sep 28, 2020, 05:16 PM | |
PRNB | Principia Biopharma Inc. | Hardiman Roy C. | Chief Business Officer | Sep 28, 2020 | Option Exercise | $100.00 | 117,761 | 11,776,100 | 0 | Sep 28, 2020, 05:14 PM | |
PRNB | Principia Biopharma Inc. | Hardiman Roy C. | Chief Business Officer | Sep 28, 2020 | Option Exercise | $100.00 | 1,916 | 191,600 | 0 | Sep 28, 2020, 05:14 PM | |
PRNB | Principia Biopharma Inc. | CHAI CHRISTOPHER Y | Chief Financial Officer | Sep 28, 2020 | Option Exercise | $100.00 | 3,799 | 379,900 | 0 | Sep 28, 2020, 05:11 PM | |
PRNB | Principia Biopharma Inc. | CHAI CHRISTOPHER Y | Chief Financial Officer | Sep 28, 2020 | Option Exercise | $100.00 | 3,302 | 330,200 | 0 | Sep 28, 2020, 05:11 PM | |
PRNB | Principia Biopharma Inc. | Goldstein David M | Chief Scientific Officer | Sep 28, 2020 | Option Exercise | $100.00 | 31,826 | 3,182,600 | 0 | Sep 28, 2020, 05:08 PM | |
PRNB | Principia Biopharma Inc. | Babler Martin | President, CEO | Sep 28, 2020 | Option Exercise | $100.00 | 1,023 | 102,300 | 0 | Sep 28, 2020, 05:07 PM | |
PRNB | Principia Biopharma Inc. | Babler Martin | President, CEO | Sep 28, 2020 | Option Exercise | $100.00 | 57,534 | 5,753,400 | 0 | Sep 28, 2020, 05:07 PM | |
PRNB | Principia Biopharma Inc. | Hardiman Roy C. | Chief Business Officer | Sep 18, 2020 | Option Exercise | $52.92 | 10,000 | 529,238 | 122,761 | Sep 22, 2020, 08:02 PM | |
PRNB | Principia Biopharma Inc. | Thomas Dolca | Chief Medical Officer | Aug 18, 2020 | Sale | $61.89 | 30,000 | 1,856,550 | 16,826 | Aug 20, 2020, 08:17 PM | |
PRNB | Principia Biopharma Inc. | CHAI CHRISTOPHER Y | Chief Financial Officer | Aug 18, 2020 | Sale | $51.18 | 15,000 | 767,723 | 11,039 | Aug 20, 2020, 08:01 PM | |
PRNB | Principia Biopharma Inc. | Goldstein David M | Chief Scientific Officer | Aug 10, 2020 | Sale | $45.86 | 12,000 | 550,297 | 37,739 | Aug 12, 2020, 08:01 PM | |
PRNB | Principia Biopharma Inc. | Thomas Dolca | Chief Medical Officer | Jul 15, 2020 | Option Exercise | $51.92 | 30,000 | 1,557,619 | 16,826 | Jul 17, 2020, 08:01 PM | |
PRNB | Principia Biopharma Inc. | Colowick Alan | Director | Jul 01, 2020 | Option Exercise | $32.27 | 15,000 | 484,065 | 7,500 | Jul 02, 2020, 08:48 PM | |
PRNB | Principia Biopharma Inc. | Babler Martin | President, CEO | Jun 23, 2020 | Sale | $32.43 | 30,000 | 972,854 | 15,810 | Jun 25, 2020, 08:07 PM | |
PRNB | Principia Biopharma Inc. | Wolff Stefani | Chief Development Officer | Jun 15, 2020 | Sale | $60.75 | 5,504 | 334,385 | 24,200 | Jun 17, 2020, 09:52 PM | |
PRNB | Principia Biopharma Inc. | Wolff Stefani | Chief Development Officer | Mar 16, 2020 | Sale | $46.15 | 5,504 | 254,031 | 28,350 | Jun 17, 2020, 09:48 PM | |
PRNB | Principia Biopharma Inc. | Wolff Stefani | Chief Development Officer | Dec 16, 2019 | Sale | $49.43 | 5,505 | 272,091 | 31,404 | Jun 17, 2020, 09:41 PM | |
PRNB | Principia Biopharma Inc. | Hardiman Roy C. | Chief Business Officer | Jun 12, 2020 | Sale | $32.94 | 10,000 | 329,406 | 122,761 | Jun 15, 2020, 08:12 PM | |
PRNB | Principia Biopharma Inc. | CHAI CHRISTOPHER Y | Chief Financial Officer | May 19, 2020 | Option Exercise | $38.35 | 13,175 | 505,280 | 11,039 | May 21, 2020, 08:01 PM | |
PRNB | Principia Biopharma Inc. | Goldstein David M | Chief Scientific Officer | May 07, 2020 | Sale | $31.58 | 12,000 | 378,927 | 36,968 | May 08, 2020, 08:05 PM | |
PRNB | Principia Biopharma Inc. | Colowick Alan | Director | May 01, 2020 | Sale | $32.30 | 1,680 | 54,272 | 840 | May 05, 2020, 08:07 PM | |
PRNB | Principia Biopharma Inc. | Colowick Alan | Director | May 05, 2020 | Sale | $32.27 | 13,320 | 429,850 | 6,660 | May 05, 2020, 08:07 PM | |
PRNB | Principia Biopharma Inc. | Wolff Stefani | Chief Development Officer | Mar 16, 2020 | Sale | $25.35 | 11,008 | 279,030 | 41,113 | Mar 18, 2020, 05:08 PM | |
PRNB | Principia Biopharma Inc. | Hardiman Roy C. | Chief Business Officer | Mar 13, 2020 | Sale | $26.64 | 10,000 | 266,434 | 121,903 | Mar 17, 2020, 05:08 PM | |
PRNB | Principia Biopharma Inc. | Babler Martin | President, CEO | Mar 03, 2020 | Sale | $63.47 | 15,000 | 952,083 | 52,094 | Mar 05, 2020, 05:21 PM | |
PRNB | Principia Biopharma Inc. | CHAI CHRISTOPHER Y | Chief Financial Officer | Feb 18, 2020 | Sale | $50.17 | 10,000 | 501,680 | 12,266 | Feb 20, 2020, 05:02 PM | |
PRNB | Principia Biopharma Inc. | Goldstein David | Chief Scientific Officer | Feb 10, 2020 | Sale | $36.95 | 12,000 | 443,386 | 36,968 | Feb 12, 2020, 07:03 PM | |
PRNB | Principia Biopharma Inc. | Thomas Dolca | Chief Medical Officer | Dec 19, 2019 | Sale | $60.00 | 495 | 29,700 | 494 | Dec 20, 2019, 09:00 PM | |
PRNB | Principia Biopharma Inc. | Babler Martin | President, CEO | Dec 17, 2019 | Sale | $52.96 | 25,000 | 1,323,996 | 73,339 | Dec 19, 2019, 09:06 PM | |
PRNB | Principia Biopharma Inc. | Babler Martin | President, CEO | Dec 18, 2019 | Sale | $53.66 | 4,500 | 241,459 | 19,196 | Dec 19, 2019, 09:06 PM | |
PRNB | Principia Biopharma Inc. | Wolff Stefani | Chief Development Officer | Dec 16, 2019 | Sale | $26.98 | 11,010 | 297,094 | 41,114 | Dec 18, 2019, 07:09 PM | |
PRNB | Principia Biopharma Inc. | Hardiman Roy C. | Chief Business Officer | Dec 13, 2019 | Sale | $27.18 | 10,000 | 271,777 | 125,143 | Dec 13, 2019, 08:04 PM | |
PRNB | Principia Biopharma Inc. | Becker Daniel J. | Director | Nov 20, 2019 | Buy | $29.94 | 55,000 | 1,646,700 | 667,600 | Nov 22, 2019, 08:07 PM | |
PRNB | Principia Biopharma Inc. | Goldstein David | Chief Scientific Officer | Nov 07, 2019 | Option Exercise | $17.14 | 20,000 | 342,729 | 39,819 | Nov 08, 2019, 09:01 PM | |
PRNB | Principia Biopharma Inc. | Becker Daniel J. | Director | Oct 28, 2019 | Buy | $33.41 | 68,404 | 2,285,549 | 603,404 | Oct 30, 2019, 04:16 PM | |
PRNB | Principia Biopharma Inc. | Becker Daniel J. | Director | Oct 29, 2019 | Buy | $33.98 | 9,196 | 312,477 | 612,600 | Oct 30, 2019, 04:16 PM | |
PRNB | Principia Biopharma Inc. | GLAXOSMITHKLINE PLC | Former 10% Owner | Oct 18, 2019 | Buy | $28.00 | 357,142 | 9,999,976 | 2,982,855 | Oct 22, 2019, 05:36 PM | |
PRNB | Principia Biopharma Inc. | George Simeon | Director | Oct 18, 2019 | Buy | $28.00 | 357,142 | 9,999,976 | 2,982,855 | Oct 22, 2019, 04:11 PM | |
PRNB | Principia Biopharma Inc. | Becker Daniel J. | Director | Oct 18, 2019 | Buy | $28.00 | 535,000 | 14,980,000 | 535,000 | Oct 22, 2019, 04:06 PM | |
PRNB | Principia Biopharma Inc. | New Leaf BPO Management II, L.L.C | 10% Owner | Aug 13, 2019 | Sale | $35.00 | 300,000 | 10,500,000 | 1,938,167 | Aug 15, 2019, 04:47 PM | |
PRNB | Principia Biopharma Inc. | ORBIMED ADVISORS LLC | 10% Owner | May 21, 2019 | Sale | $30.25 | 1,000,000 | 30,250,000 | 1,605,713 | May 22, 2019, 12:43 PM | |
PRNB | Principia Biopharma Inc. | Mehra Anand | 10% Owner | Sep 18, 2018 | Buy | $17.00 | 270,000 | 4,590,000 | 2,038,208 | Sep 20, 2018, 07:02 PM | |
PRNB | Principia Biopharma Inc. | OrbiMed Capital GP IV LLC | 10% Owner | Sep 18, 2018 | Buy | $17.00 | 250,000 | 4,250,000 | 2,605,713 | Sep 20, 2018, 06:59 PM | |
PRNB | Principia Biopharma Inc. | Becker Daniel J. | Director | Sep 18, 2018 | Buy | $17.00 | 270,000 | 4,590,000 | 437,537 | Sep 20, 2018, 06:58 PM | |
PRNB | Principia Biopharma Inc. | New Leaf BPO Associates II, L.P. | 10% Owner | Sep 18, 2018 | Buy | $17.00 | 270,000 | 4,590,000 | 437,537 | Sep 20, 2018, 06:53 PM | |
PRNB | Principia Biopharma Inc. | George Simeon | Director | Sep 18, 2018 | Buy | $17.00 | 270,000 | 4,590,000 | 2,625,713 | Sep 20, 2018, 06:50 PM | |
PRNB | Principia Biopharma Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Sep 18, 2018 | Buy | $17.00 | 270,000 | 4,590,000 | 2,625,713 | Sep 20, 2018, 05:18 PM | |
PRNB | Principia Biopharma Inc. | AKKARAJU SRINIVAS | Director | Sep 18, 2018 | Buy | $17.00 | 175,000 | 2,975,000 | 383,480 | Sep 20, 2018, 04:14 PM |